CLINICAL_TRIALS
trial_result
· 2023-05-01
Clinical Trial Update: SGLT2 Inhibition: Uric Acid Excretion Study [Phase 4]
Summary
Phase 4 clinical trial update on SGLT2 inhibition evaluating uric acid excretion in individuals with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Amsterdam UMC, location VUmc | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED